{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:47:51Z","timestamp":1787615271121,"version":"build-2736575974"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2434,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1111\/j.1365-2133.2008.08893.x","type":"journal-article","created":{"date-parts":[[2008,10,13]],"date-time":"2008-10-13T09:30:17Z","timestamp":1223890217000},"page":"203-205","source":"Crossref","is-referenced-by-count":20,"title":["Treatment of acrodermatitis continua of Hallopeau with adalimumab"],"prefix":"10.1093","volume":"160","author":[{"given":"C.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2008.08893.x-BIB1","first-page":"39","article-title":"Sur une asphyxie locale des extr\u00e9miti\u00e9s avec polydactilite suppurative chronique et pouss\u00e9es \u00e9ph\u00e9m\u00e8res de dermatite pustuleuse diss\u00e9min\u00e9e et sym\u00e9trique","volume":"1","author":"Hallopeau","year":"1890","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"10.1111\/j.1365-2133.2008.08893.x-BIB2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/archderm.136.7.925-c","article-title":"Chronic pustular eruption of the thumbs. Diagnosis: acrodermatitis continua of Hallopeau (ACH)","volume":"136","author":"Yerushalmi","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08893.x-BIB3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2133.1968.tb11947.x","article-title":"Generalized pustular psoriasis","volume":"80","author":"Baker","year":"1968","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08893.x-BIB4","first-page":"126","article-title":"Breaking the relentless course of Hallopeau\u2019s acrodermatitis by dapsone","volume":"9","author":"Nikkels","year":"1999","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08893.x-BIB5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2133.2003.05761.x","article-title":"Successful treatment of acrodermatitis continua of Hallopeau by the tumour necrosis factor-\u03b1 inhibitor infliximab","volume":"150","author":"Mang","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08893.x-BIB6","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1365-4632.2007.03251.x","article-title":"Lack of efficacy of etanercept in acrodermatitis continua of Hallopeau","volume":"46","author":"Adi\u015fen","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08893.x-BIB7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2133.2005.06759.x","article-title":"Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin","volume":"153","author":"Tobin","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08893.x-BIB8","first-page":"241","article-title":"Molecular differences in anticytokine therapies","volume":"21","author":"Calabrese","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1365-2133.2008.08893.x-BIB9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2007.09.010","article-title":"Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase III trial","volume":"58","author":"Menter","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08893.x-BIB10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jaad.2006.05.027","article-title":"Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study","volume":"55","author":"Gordon","year":"2006","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2008.08893.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2008.08893.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:43:04Z","timestamp":1676382184000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/160\/1\/203\/6641684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08893.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}